Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("CURRIE GA")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 29

  • Page / 2
Export

Selection :

  • and

EFFECT OF ACTIVE IMMUNIZATION WITH IRRADIATED TUMOUR CELLS ON SPECIFIC SERUM INHIBITORS OF CELL-MEDIATED IMMUNITY IN PATIENTS WITH DISSEMINATED CANCER = EFFET DE L'IMMUNISATION ACTIVE AU MOYEN DE CELLULES TUMORALES IRRADIEES SUR LES INHIBITEURS SERIQUES SPECIFIQUES DE L'IMMUNITE A MEDIATION CELLULAIRE CHEZ DES MALADES ATTEINTS DE CANCER DISSEMINECURRIE GA.1973; BRIT. J. CANCER; G.B.; DA. 1973; VOL. 28; NO 1; PP. 25-35; BIBL. 8REF.Serial Issue

SERUM LYSOZYME AS A MARKER OF HOST RESISTANCE. II. PATIENTS WITH MALIGNANT MELANOMA, HYPERNEPHROMA OR BREAST CARCINOMA.CURRIE GA.1976; BRIT. J. CANCER; G.B.; DA. 1976; VOL. 33; NO 6; PP. 593-599; BIBL. 8 REF.Article

PROMOTION OF FIBROSARCOMA CELL GROWTH BY PRODUCTS OF SYNGENEIC HOST MACROPHAGESCURRIE GA.1981; BR. J. CANCER; ISSN 0007-0920; GBR; DA. 1981; VOL. 44; NO 4; PP. 506-513; BIBL. 20 REF.Article

ACTIVATED MACROPHAGES KILL TUMOUR CELLS BY RELEASING ARGINASE.CURRIE GA.1978; NATURE; GBR; DA. 1978; VOL. 273; NO 5665; PP. 758-759; BIBL. 9 REF.Article

SERUM LYSOZYME AS A MARKER OF HOST RESISTANCE. II. PATIENTS WITH MALIGNANT MELANOMA, HYPERNEPHROMA OR BREAST CARCINOMACURRIE GA.1976; BRIT. J. CANCER; G.B.; DA. 1976; VOL. 33; NO 6; PP. 593-599; BIBL. 8 REF.Article

PLATELET-DERIVED GROWTH-FACTOR REQUIREMENTS FOR IN VITRO PROLIFERATION OF NORMAL AND MALIGNANT MESENCHYMAL CELLSCURRIE GA.1981; BR. J. CANCER; ISSN 0007-0920; GBR; DA. 1981; VOL. 43; NO 3; PP. 335-343; BIBL. 12 REF.Article

ACTIVE IMMUNOTHERAPY AS AN ADJUNCT TO CHEMOTHERAPY IN THE TREATMENT OF DISSEMINATED MALIGNANT MELANOMA: A PILOT STUDYCURRIE GA; MCELWAIN TJ.1975; BRIT. J. CANCER; G.B.; DA. 1975; VOL. 31; NO 2; PP. 143-156; BIBL. 22REF.Article

SERUM MEDIATED INHIBITION OF THE IMMUNOLOGICAL REACTIONS OF THE PATIENT TO HIS OWN TUMOUR: A POSSIBLE ROLE FOR CIRCULATING ANTIGEN = INHIBITION PAR L'INTERMEDIAIRE DU SERUM DES REACTIONS IMMUNOLOGIQUES DU MALADE VIS-A-VIS DE SA PROPRE TUMEUR: UN ROLE POSSIBLE DE L'ANTIGENE CIRCULANTCURRIE GA; BASHAM C.1972; BRIT. J. CANCER; G.B.; DA. 1972; VOL. 26; NO 6; PP. 427-438; BIBL. 8REF.Serial Issue

DIFFERENTIAL ARGININE DEPENDENCE AND THE SELECTIVE CYTOTOXIC EFFECTS OF ACTIVATED MACROPHAGES FOR MALIGNANT CELLS IN VITROCURRIE GA; BASHAM C.1978; BRIT. J. CANCER; GBR; DA. 1978; VOL. 38; NO 6; PP. 653-659; BIBL. 21 REF.Article

INFLUENCE OF TUMOUR GROWTH ON THE EVOLUTION OF CYTOTOXIC LYMPHOID CELLS IN RATS BEARING A SPONTANEOUSLY METASTASIZING SYNGENIC FIBROSARCOMA = INFLUENCE DU DEVELOPPEMENT TUMORAL SUR L'EVOLUTION DE CELLULES LYMPHOIDES CYTOTOXIQUES CHEZ DES RATS PORTEURS D'UN FIBROSARCOME SYNGENIQUE FORMANT SPONTANEMENT DES METASTASESCURRIE GA; GAGE JO.1973; BRIT. J. CANCER; G.B.; DA. 1973; VOL. 28; NO 2; PP. 136-146; BIBL. 14REF.Serial Issue

MONOCYTE MATURATION AND PROGNOSIS IN PRIMARY BREAST CANCERTAYLOR SA; CURRIE GA.1979; BRIT. MED. J.; GBR; DA. 1979; NO 6170; PP. 1050-1051; BIBL. 5 REF.Article

MONOCYTES AND MACROPHAGES IN MALIZNANT MELANOMA. I. PERIPHERAL BLOOD MACROPHAGE PRECURSORS.CURRIE GA; HEDLEY DW.1977; BRIT. J. CANCER; G.B.; DA. 1977; VOL. 36; NO 1; PP. 1-6; BIBL. 14 REF.Article

SERUM LYSOZYME AS A MARKER OF HOST RESISTANCE. I. PRODUCTION BY MACROPHAGES RESIDENT IN RAT SARCOMATACURRIE GA; ECCLES SA.1976; BRIT. J. CANCER; G.B.; DA. 1976; VOL. 33; NO 1; PP. 51-59; BIBL. 12 REF.Article

MONOCYTES AND MACROPHAGES IN MALIGNANT MELANOMA. II. LYSIS OF ANTIBODY-COATED HUMAN ERYTHROCYRES AS AN ASSAY OF MONOCYTE FUNCTION.NYHOLM RE; CURRIE GA.1978; BRIT. J. CANCER; GBR; DA. 1978; VOL. 37; NO 3; PP. 337-344; BIBL. 16 REF.Article

SYNGENEIC IMMUNE SERUM SPECIFICALLY INHIBITS THE MOTILITY OF TUMOUR CELLS = LE SERUM IMMUN SYNGENIQUE INHIBE SPECIFIQUEMENT LA MOTILITE DE CELLULES TUMORALESCURRIE GA; SIME GC.1973; NATURE NEW BIOL.; G.B.; DA. 1973; VOL. 241; NO 113; PP. 284-285; BIBL. 10REF.Serial Issue

MONOCYTES AND MACROPHAGES IN MALIGNANT MELANOMA. III. REDUCTION OF NITROBLUE TETRAZOLIUM BY PERIPHERAL BLOOD MONOCYTES.HEDLEY DW; CURRIE GA.1978; BRIT. J. CANCER; GBR; DA. 1978; VOL. 37; NO 5; PP. 747-752; BIBL. 22 REF.Article

ACTIVATED MACROPHAGES RELEASE A FACTOR WHICH LYSES MALIGNANT CELLS BUT NOT NORMAL CELLS = LES MACROPHAGES ACTIVES LIBERENT UN FACTEUR QUI LYSE LES CELLULES MALIGNES MAIS NON LES CELLULES NORMALESCURRIE GA; BASHAM C.1975; J. EXPER. MED.; U.S.A.; DA. 1975; VOL. 142; NO 6; PP. 1600-1605; BIBL. 15 REF.Article

INHIBITION OF LEUKAEMIA BLAST CELL MOTILITY AS A TEST FOR SPECIFIC ANTIBODY IN ACUTE ADULT MYELOGENOUS LEUKAEMIA.KATZ J; CURRIE GA; OLIVER RTD et al.1977; BRIT. J. HAEMATOL.; G.B.; DA. 1977; VOL. 36; NO 1; PP. 59-66; BIBL. 10 REF.Article

A SEROLOGICALLY DETECTED TUMOUR-SPECIFIC MEMBRANE ANTIGEN OF MURINE LYMPHOMAS WHICH IS NOT THE TARGET FOR SYNGENEIC GRAFT REJECTIONDAVEY GC; CURRIE GA; ALEXANDER P et al.1979; BRIT. J. CANCER; GBR; DA. 1979; VOL. 40; NO 1; PP. 168-170; BIBL. 6 REF.Article

SPECIFIC ACTIVE IMMUNOTHERAPY DOES NOT PROLONG SURVIVAL IN SURGICALLY TREATED PATIENTS WITH STAGE IIB MALIGNANT MELANOMA AND MAY PROMOTE EARLY RECURRENCE.HEDLEY DW; MCELWAIN TJ; CURRIE GA et al.1978; BRIT. J. CANCER; G.B.; DA. 1978; VOL. 37; NO 4; PP. 491-496; BIBL. 11 REF.Article

IMMUNITY AS THE PREDOMINANT FACTOR DETERMINING METASTASIS BY MURINE LYMPHOMASDAVEY GC; CURRIE GA; ALEXANDER P et al.1979; BRIT. J. CANCER; GBR; DA. 1979; VOL. 40; NO 4; PP. 590-596; BIBL. 11 REF.Article

MONOCYTES AND MACROPHAGES IN MALIGNANT MELANOMA. IV: EFFECTS OF C. PARVUM ON MONOCYTE FUNCTIONHEDLEY DW; NYHOLM RE; CURRIE GA et al.1979; BRIT. J. CANCER; GBR; DA. 1979; VOL. 39; NO 5; PP. 558-565; BIBL. 18 REF.Article

MICROENVIRONMENTAL ARGININE DEPLETION BY MACROPHAGES IN VIVOCURRIE GA; GYURE L; CIFUENTES L et al.1979; BRIT. J. CANCER; GBR; DA. 1979; VOL. 39; NO 6; PP. 613-620; BIBL. 20 REF.Article

AUTOANTIBODY TO MICROTUBULES IN INFECTIOUS MONONUCLEOSISWHITEHOUSE JMA; FERGUSON N; CURRIE GA et al.1974; CLIN. EXPER. IMMUNOL.; G.B.; DA. 1974; VOL. 17; NO 2; PP. 227-235; BIBL. 1P.Article

TUMOUR REGRESSION AND SURVIVAL OF PATIENTS WITH DISSEMINATED MALIGNANT MELANOMA TREATED WITH CHEMOTHERAPY AND SPECIFIC ACTIVE IMMUNOTHERAPY.HEDLEY DW; MCELWIN TJ; CURRIE GA et al.1977; EUROP. J. CANCER; G.B.; DA. 1977; VOL. 13; NO 20; PP. 1169-1173; BIBL. 11 REF.Article

  • Page / 2